z-logo
open-access-imgOpen Access
Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study
Author(s) -
Farid H. Mahmud,
Antoine Clarke,
Kariym C. Joachim,
Esther Assor,
Charlotte McDonald,
Fred Saibil,
Heather Lochnan,
Zubin Punthakee,
Amish Parikh,
Andrew Advani,
Baiju R. Shah,
Bruce A. Perkins,
Caroline Zuijdwijk,
David R. Mack,
Dror Koltin,
Emilia N. De Melo,
Eugene Hsieh,
Geetha Mukerji,
Jeremy Gilbert,
Kevin Bax,
Margaret L. Lawson,
Maria Cino,
Melanie Beaton,
Navaaz Saloojee,
Olivia Lou,
Patricia Gallego,
Přemysl Berčík,
Robyn L. Houlden,
Ronnie Aronson,
Susan Kirsch,
William G. Paterson,
Margaret Marcon
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc19-1944
Subject(s) - medicine , asymptomatic , postprandial , glycemic , diabetes mellitus , gluten free , gastroenterology , type 2 diabetes , randomized controlled trial , type 1 diabetes , disease , endocrinology
OBJECTIVE To describe celiac disease (CD) screening rates and glycemic outcomes of a gluten-free diet (GFD) in patients with type 1 diabetes who are asymptomatic for CD. RESEARCH DESIGN AND METHODS Asymptomatic patients (8–45 years) were screened for CD. Biopsy-confirmed CD participants were randomized to GFD or gluten-containing diet (GCD) to assess changes in HbA1c and continuous glucose monitoring over 12 months. RESULTS Adults had higher CD-seropositivity rates than children (6.8% [95% CI 4.9–8.2%, N = 1,298] vs. 4.7% [95% CI 3.4–5.9%, N = 1,089], P = 0.035) with lower rates of prior CD screening (6.9% vs. 44.2%, P < 0.0001). Fifty-one participants were randomized to a GFD (N = 27) or GCD (N = 24). No HbA1c differences were seen between the groups (+0.14%, 1.5 mmol/mol; 95% CI −0.79 to 1.08; P = 0.76), although greater postprandial glucose increases (4-h +1.5 mmol/L; 95% CI 0.4–2.7; P = 0.014) emerged with a GFD. CONCLUSIONS CD is frequently observed in asymptomatic patients with type 1 diabetes, and clinical vigilance is warranted with initiation of a GFD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom